Page 6 - U.S. Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Jan 22, 2026

Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

719 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
VTGN	US$0.66	-1.2%	-77.7%	US$25.0m	n/a	36.3	54.6%	n/a
VERA	US$48.72	5.3%	42.9%	US$3.2b	US$75.15	8.7	54.6%	n/a
IONS	US$81.79	7.2%	135.4%	US$13.2b	US$90.63	13.7	54.4%	n/a
XGN	US$4.89	1.2%	22.6%	US$107.2m	US$14.71	1.7	54.2%	n/a
PYPD	US$4.81	9.6%	50.3%	US$76.4m	US$12.25	5.2	54.2%	n/a
AXSM	US$186.98	7.4%	80.0%	US$9.5b	US$210.19	16.8	54.1%	n/a
MAIA	US$2.40	50.9%	21.2%	US$89.5m	US$12.14	2203.9	53.9%	n/a
RCEL	US$4.13	19.4%	-53.9%	US$118.9m	US$7.06	1.7	53.8%	n/a
ENSC	US$0.89	-1.3%	-88.8%	US$3.3m	US$19.23	2.7	53.6%	n/a
HRTX	US$1.45	-2.7%	-20.8%	US$265.9m	US$4.50	1.7	53.3%	n/a
NTLA	US$15.90	27.2%	44.7%	US$1.8b	US$22.27	32.0	53.3%	n/a
LGVN	US$0.55	-2.7%	-67.7%	US$11.4m	US$6.86	8.1	53.2%	n/a
RVPH	US$0.34	-3.9%	-82.2%	US$38.2m	US$4.81	8.6	53.0%	n/a
MYNZ	US$1.18	-0.8%	-73.2%	US$10.7m	US$14.00	16.2	53.0%	n/a
ANNX	US$6.96	13.0%	64.2%	US$1.0b	US$14.33	6.4	52.8%	n/a
QURE	US$22.69	3.2%	43.3%	US$1.4b	US$55.27	89.7	52.6%	n/a
SLS	US$4.51	17.4%	356.1%	US$779.9m	US$6.83	16.8	52.5%	n/a
TLPH	US$1.01	1.8%	42.3%	US$46.6m	US$3.25	1681.3	52.4%	n/a
ETTX	US$2.19	0%	-14.8%	US$104.8m	US$2.00	6.3	52.3%	n/a
CGON	US$55.85	5.2%	81.6%	US$4.6b	US$79.21	2072.3	52.3%	n/a
RZLT	US$3.27	16.4%	-34.5%	US$280.0m	US$4.25	2.1	52.2%	n/a
TVTX	US$29.73	4.7%	42.9%	US$2.5b	US$41.93	6.1	52.2%	n/a
TOVX	US$0.21	-0.1%	-84.9%	US$6.8m	US$7.00	1.1	52.1%	n/a
DFTX	US$16.97	10.3%	136.0%	US$1.7b	US$28.67	12.8	52.0%	n/a

Page 6 of 30